RecruitingNot ApplicableNCT06463652

Cerclage With Progesterone Versus Progesterone Only in Singleton Pregnancies

Cervical Cerclage With Vaginal Progesterone Versus Vaginal Progesterone Only for Preterm Birth Prevention in Women With a Singleton Pregnancy and a Short Cervical Length: a Randomized Clinical Trial


Sponsor

Mỹ Đức Hospital

Enrollment

328 participants

Start Date

Jun 26, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study compares the effectiveness of cervical cerclage with vaginal progesterone to vaginal progesterone only for the prevention of preterm birth in women with a singleton pregnancy and a short cervical length. Participants will be randomly assigned in a 1:1 ratio to receive cerclage plus progesterone or progesterone only.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Cervical cerclage and a drug called Vaginal progesterone for people with preterm birth and short cervix. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURECervical cerclage

Cervical cerclage using the McDonald technique under anaesthesia.

DRUGVaginal progesterone

Cyclogest® 200mg, Actavis, United Kingdom, applied once daily at bedtime.


Locations(1)

My Duc Hospital

Ho Chi Minh City, Ho Chi Minh City, Vietnam

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06463652


Related Trials